Top Story

Morning Read: Soon-Shiong shares good news on Adenovirus vaccine, Olympus settles kickback charges for $306M

Also, GSK chief bemoans lack of price transparency in the U.S., feds investigate pharma-PBM contracts and Memorial Hermann gets its first physician CEO.

Soon-Shiong ATA2015

TOP STORIES

At an investor conference Tuesday, NantWorks CEO Dr. Patrick Soon-Shiong shared promising data from a Phase II study of a genetically engineered Adenovirus vaccine for colon cancer. The vaccine more than doubled the survival rate among a cohort of 30 patients with end-stage colon cancer.

Soon-Shiong also announced that the FDA has cleared the vaccine for clinical trials in patients with HER2-positive breast cancer. — Business Wire

Olympus has agreed to pay $306 million to the federal government, all 50 states and D.C. to settle kickback allegations. The device-maker also reportedly reached a three-year deferred prosecution agreement with the United States Attorney’s Office in New Jersey. — MassDevice

LIFE SCIENCES

GlaxoSmithKline CEO Andrew Witty said lack of price transparency is a major reason why drugs — and healthcare in general — cost so much in the U.S. — Marketplace

presented by

VistaGen Therapeutics is moving its stock to the Nasdaq on Wednesday. The South San Francisco, California-based company hopes to raise $10 million with a new stock offering. — PR Newswire

Biopharma company Aptinyx has secured $65 million in Series A funding, led by New Leaf Venture Partners. — PE Hub

PAYERS-PROVIDERS

Dr. Benjamin Chu has officially started as CEO of Memorial Herrmann Health System in Houston. He’s the first physician to lead the organization. — Houston Business Journal

Physicians are starting to win battles against recurring tests of their skills, but could that compromise patient safety? — STAT

The Ohio Department of Mental Health and Addiction Services unintentionally disclosed personal data of 59,000 state residents who had received mental health treatment. — Cincinnati Business Courier

Teamsters Local 727, which filed charges of unfair labor practices against CVS to the National Labor Relations Board last week, held protests outside several Chicago-area CVS stores on Tuesday about over pharmacists’ working conditions. — Chicago Tribune

TECHNOLOGY

The U.S. market for virtual medical visits will grow by 17.8 percent annually from 2015 to 2021, said Frost & Sullivan. — PR Newswire

Medical billing startup Simplee has closed a $20 million venture round, led by Social Capital and American Express Ventures. — VentureBeat

i2i Systems, a population health service provider based in Santa Rosa, California, has closed an investment round of an undisclosed amount and will open a sales and management office in the Nashville, Tennessee, area. — i2i Systems

Physician social network Sermo has added an agile market research tool called Sermo RealTime. — Business Wire

The makers of a wearable concussion sensor — finalists on the TBS reality show “America’s Greatest Makers” — demonstrated their invention to Conan O’Brien on Monday:

POLITICS

Federal prosecutors in New York are investigating contracts between pharma companies and PBMs. The latest drug-makers to reveal that they are being scrutinized are Johnson & Johnson, Merck and Endo International. — Reuters

Sen. Ron Johnson (R-Wisconsin) has introduced “right to try” legislation for terminally ill patients. — STAT

Sen. Bernie Sanders (D-Vermont) became the first major-party presidential candidate to endorse a California ballot measure that would allow the state to purchase prescription drugs at the lowest rates available to the federal government. — Business Wire

A LITTLE BIT EXTRA

At the request of lawmakers and food companies, the FDA is reviewing its official definition of “healthy” for the first time since 1994. Right now, almonds aren’t officially healthier than Pop-Tarts. — The Wall Street Journal